BioHarvest Sciences to Report Third Quarter 2026 Financial Results on November 12, 2026
Key Highlights
- ➤Q3 2026 results scheduled before market open November 12, 2026
- ➤Earnings call set for 8:00 AM Eastern Time on November 12
- ➤BioHarvest highlights strategic transformation toward a CDMO-focused company
- ➤CEO cites opportunities for scalable growth and long-term profitability
Expert Statements
Zaki Rakib, Chief Executive Officer of BioHarvest Sciences
“I invite our shareholders to join our upcoming Q3 earnings call, where I will share important developments and achievements that are shaping BioHarvest's future as a CDMO-focused company.”
Zaki Rakib, Chief Executive Officer of BioHarvest Sciences
“Beyond the quarterly financial results, I look forward to discussing the progress of our strategic transformation and the opportunities we see for building a scalable business with significant long-term revenue growth potential and profitability.”
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - October 29, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (TASE: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a leader in Botanical Synthesis technology and sustainable plant-based molecule development, today announced that it will report its third quarter 2026 financial results before the market opening on Thursday, November 12, 2026. The Company will host a conference call and webcast at 8:00 AM Eastern Time to discuss the results and provide an update on business operations.
"I invite our shareholders to join our upcoming Q3 earnings call, where I will share important developments and achievements that are shaping BioHarvest's future as a CDMO-focused company," commented Chief Executive Officer Zaki Rakib. "Beyond the quarterly financial results, I look forward to discussing the progress of our strategic transformation and the opportunities we see for building a scalable business with significant long-term revenue growth potential and profitability."
Get started
Create a free account to read the full story.